Scholarlink

<p>Approach bias modification (ApBM), a computerized training designed to retrain involuntary approach action tendencies toward drug-related cues, has been shown to reduce relapse rates when added to treatment-as-usual (TAU) in alcohol use disorder. A potential working mechanism involves reduced neural drug cue-reactivity in reward-related brain regions. In smoking cessation, however, the efficacy and neural mechanisms of ApBM remain unclear. In this randomized-controlled trial, individuals with chronic, moderate-to-heavy tobacco dependence (<i>N</i> = 117, <i>M</i><sub>age&#xa0;</sub>=&#xa0;41.5, 45.3% female) received a one-day smoking cessation intervention (TAU) and were subsequently randomized to complete seven sessions of ApBM (TAU+ApBM), Sham control training (TAU+Sham), or no training (TAU-only). Neural reactivity toward smoking-related versus neutral stimuli (smoking cue-reactivity) was assessed using functional magnetic resonance imaging (fMRI) before and after intervention. Abstinence was the primary clinical outcome. Results showed no significant group×time interactions on cue-reactivity, and ApBM did not enhance abstinence rates. In the precuneus (sensorimotor region), <i>increased</i> cue-reactivity following ApBM was associated with higher long-term abstinence probability, while the control groups showed the opposite descriptive pattern. In conclusion, ApBM did not reduce smoking cue-reactivity in reward-related regions, consistent with the lack of beneficial effects on clinical outcomes. Alternative neural target processes (e.g., sensorimotor-related) and respective training procedures should be explored.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effects of approach bias modification on smoking cue-reactivity in individuals who smoke: A randomized controlled fMRI study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月28日

查看全文
  • Franziska Motka,
  • Haoye Tan,
  • Sabine Vollstädt-Klein,
  • Katja Bertsch,
  • Charlotte E. Wittekind

摘要

Approach bias modification (ApBM), a computerized training designed to retrain involuntary approach action tendencies toward drug-related cues, has been shown to reduce relapse rates when added to treatment-as-usual (TAU) in alcohol use disorder. A potential working mechanism involves reduced neural drug cue-reactivity in reward-related brain regions. In smoking cessation, however, the efficacy and neural mechanisms of ApBM remain unclear. In this randomized-controlled trial, individuals with chronic, moderate-to-heavy tobacco dependence (N = 117, Mage = 41.5, 45.3% female) received a one-day smoking cessation intervention (TAU) and were subsequently randomized to complete seven sessions of ApBM (TAU+ApBM), Sham control training (TAU+Sham), or no training (TAU-only). Neural reactivity toward smoking-related versus neutral stimuli (smoking cue-reactivity) was assessed using functional magnetic resonance imaging (fMRI) before and after intervention. Abstinence was the primary clinical outcome. Results showed no significant group×time interactions on cue-reactivity, and ApBM did not enhance abstinence rates. In the precuneus (sensorimotor region), increased cue-reactivity following ApBM was associated with higher long-term abstinence probability, while the control groups showed the opposite descriptive pattern. In conclusion, ApBM did not reduce smoking cue-reactivity in reward-related regions, consistent with the lack of beneficial effects on clinical outcomes. Alternative neural target processes (e.g., sensorimotor-related) and respective training procedures should be explored.